1 / 21

European Stakeholders Workshop ( October 11, 2001) Human Health Risk Assessment

European Stakeholders Workshop ( October 11, 2001) Human Health Risk Assessment - Progress and Lessons Learned - Dr. Christeine Lally Chair: HERA Human Health Task Force. Human Health Task Force. C. Poelloth, C. Arregui, J. Backmann – HERA Secretariat. C. Lally (P&G) - Chair

talib
Download Presentation

European Stakeholders Workshop ( October 11, 2001) Human Health Risk Assessment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. European Stakeholders Workshop • ( October 11, 2001) • Human Health Risk Assessment • - Progress and Lessons Learned - • Dr. Christeine Lally • Chair: HERA Human Health Task Force HERA European Stakeholders Workshop: Brussels, Oct 2001

  2. Human Health Task Force C. Poelloth, C. Arregui, J. Backmann – HERA Secretariat • C. Lally (P&G) - Chair • G. Holland (Unilever) • F. Bartnik (Henkel) • N. Fedtke (Henkel) • J. Boyd (Colgate) • G. Helmlinger (P&G) • S. Kirkwood (McBride) • F. Bielen (P&G) • W. Aulmann (Cognis) • O. Grundler (BASF) • S. Jacobi (Degussa) • R. Kreiling (Clariant) • T. Roth (Clariant) • M. Maier (ZEODET) • P. Martin (Rhodia) • H. Messinger (Cognis) • J.R. Plautz (Ciba) • G. Veenstra (Shell) HERA European Stakeholders Workshop: Brussels, Oct 2001

  3. Human Health Task Force • THE PROCESS: • Focus on a tiered approach to both hazard and exposure assessment; on chemicals used primarily in household detergent and cleaning products; on consumer use of these products (i.e. not professional use or workplace exposure) • focus on intended use but also consider other foreseeable uses and exposure fromcommon accidents • focus on hazards of greatest concern for the general public from the use of these products HERA European Stakeholders Workshop: Brussels, Oct 2001

  4. Human Health Task Force • Human Health Conclusions • valid for European Usage • and HERA product categories HERA Human Health Risk Assessment builds on EU Technical Guidance Document for New and Existing substances HERA European Stakeholders Workshop: Brussels, Oct 2001

  5. Human Health Task Force • The HERA methodology follows a tiered approach: • Consider possible uses of chemicals in household detergent and cleaning products • Consider consumer activity during cleaning tasks - review also foreseeable other uses of products • Consider hazards which are most likely to be relevant for known product uses and exposures (e.g. is dermal contact likely? could ingestion occur inadvertently?) • Consider the likelihood that the consumer could be exposed at levels which could be harmful to health i.e. is the consumer at risk? HERA European Stakeholders Workshop: Brussels, Oct 2001

  6. What do consumers do with HERA products ? ? HERA European Stakeholders Workshop: Brussels, Oct 2001

  7. Human Health Task Force • USE & EXPOSURE • Identify • which finished product category (laundry compact, fabric conditioner, toilet cleaner….) • chemical concentration (% in finished product, range) • type of application (powder, tablet, spray, wipe….) and how is product used HERA European Stakeholders Workshop: Brussels, Oct 2001

  8. HERA brings Formulators together…. HERA European Stakeholders Workshop: Brussels, Oct 2001

  9. HERA brings Formulators together…. Formulator companies asked to provide (in confidence): • Use levels of Phase 1A and 1B chemicals in their finished products • List of product categories where chemicals are currently used • Published or in-house data on consumer habits and practices for product categories (at least provide ‘recommended use’) HERA European Stakeholders Workshop: Brussels, Oct 2001

  10. Human Health Task Force • USE & EXPOSURE • HERA provides simple multiplicative mathematical models – building on consumer exposure equations in EU TGD and in ECETOC Technical Reports • HERA uses real data (formulators) or, if unavailable, it uses ‘reasonable’ defaults (based on expert judgement) • HERA uses a ‘reasonable worst case’ scenario in first step (tiered approach) • HERA checks exposure estimate for ‘realism’ • HERA considers need for more refined exposure estimate HERA European Stakeholders Workshop: Brussels, Oct 2001

  11. HERA brings Formulators together…. Estimate of Consumer Exposure HERA European Stakeholders Workshop: Brussels, Oct 2001

  12. + • HAZARD • Producer companies asked to: • collect available toxicology data on chemical – IUCLID, SIDS, IPCS, in-house company data etc. • consider toxicological endpoints most relevant for use - endpoints of interest largely driven by predicted exposure; identify no-effect-levels and possible data gaps • validate data based on current standards (e.g. Klimisch) - evaluate relevant older data; consider human experience And Formulator companies asked to provide: • finished product safety data where available and useful HERA European Stakeholders Workshop: Brussels, Oct 2001

  13. Potential for Consumer Hazard HERA European Stakeholders Workshop: Brussels, Oct 2001

  14. HERA Risk Assessment elements…. HERA European Stakeholders Workshop: Brussels, Oct 2001

  15. HERA brings Producers & Formulators together…. • HOWEVER….these assessment activities are not two distinct processes running in isolation ! • HERA identifies a Substance Team for each chemical in programme • Substance Team is a unique ‘platform of cooperation’ between producer and formulator • Team dialogue ensures that Exposure and Hazard exercises are linked; • highlight early on any potential issues needing more attention • apply team resources to areas of concern and uncertainty • compare ‘bridging data’ – exchange expert judgement opinions • identify needs for new approach or further research HERA European Stakeholders Workshop: Brussels, Oct 2001

  16. Is the consumer at risk…? • compare relevant hazard(s) with foreseeable exposure(s) for consumer • ratio of “no observed adverse effect level” and “exposure”  Margin of Exposure or MOE [NOAEL/Exposure = MOE] • how does the MOE help to develop the human health conclusions of the risk assessment ? HERA European Stakeholders Workshop: Brussels, Oct 2001

  17. Human Health Task Force • The MOE needs to take account of: ….the Uncertainties and Variabilities in the Hazard and Exposure assessments e.g. • assumptions and reliability of exposure estimates (both from modelling and from measured data) • adequacy and relevancy of hazard data set • the data extrapolations between and within species • use of less-than-lifetime exposures HERA European Stakeholders Workshop: Brussels, Oct 2001

  18. Is the consumer at risk…? • The MOE may indicate that product use is safe…… or • There may be a need to revise the assessment…… ACTION: • review exposure estimates • review hazard dataset • consider product safety data • use human experience data • get more data…. (exposure, hazard…) • consider the option of risk management HERA European Stakeholders Workshop: Brussels, Oct 2001

  19. Human Health Task Force The Human Health Risk Assessment conclusion …. • uses the combined knowledge about chemicals from the Producers and Formulators – the Partnership • uses the expert judgement of experienced toxicologists and builds on their familiarity with products • provides transparency in arguments and decisions and a consensus opinion • provides a common basis to allow risk management decisions to be considered HERA European Stakeholders Workshop: Brussels, Oct 2001

  20. Human Health Task Force • SOME LEARNINGS… • collection and comparing exposure data is not easy – downstream use is complex • exposure from indirect contact with chemicals is difficult to estimate • Poison Control Centre (PCC) reports helpful for ‘safety’ after accidental exposures • combined expertise and experience of toxicologists from Producer and Formulator companies adds a synergistic value to the HERA risk assessments HERA European Stakeholders Workshop: Brussels, Oct 2001

  21. On behalf of the HERA Human Health Task Force……… Thank you! HERA European Stakeholders Workshop: Brussels, Oct 2001

More Related